Todd Asset Management LLC lessened its position in Koninklijke Philips (NYSE:PHG – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,122 shares of the technology company’s stock after selling 1,194 shares during the quarter. Todd Asset Management LLC’s holdings in Koninklijke Philips were worth $484,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC lifted its holdings in shares of Koninklijke Philips by 0.6% in the third quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after purchasing an additional 35,935 shares in the last quarter. JPMorgan Chase & Co. raised its position in Koninklijke Philips by 315.0% during the third quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock valued at $8,040,000 after buying an additional 186,520 shares during the period. International Assets Investment Management LLC acquired a new position in Koninklijke Philips during the third quarter valued at $1,360,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Koninklijke Philips in the 3rd quarter worth about $4,622,000. Finally, Stifel Financial Corp boosted its position in Koninklijke Philips by 16.4% during the 3rd quarter. Stifel Financial Corp now owns 195,222 shares of the technology company’s stock worth $6,388,000 after acquiring an additional 27,536 shares during the period. Institutional investors and hedge funds own 13.67% of the company’s stock.
Koninklijke Philips Stock Up 2.9 %
PHG opened at $26.74 on Wednesday. The company has a market capitalization of $25.13 billion, a PE ratio of -31.83, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77. The business has a 50-day moving average of $26.29 and a 200-day moving average of $28.10. Koninklijke Philips has a fifty-two week low of $19.75 and a fifty-two week high of $32.91. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74.
Koninklijke Philips Cuts Dividend
The business also recently announced an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be issued a $0.886 dividend. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a yield of 2.9%. Koninklijke Philips’s dividend payout ratio (DPR) is currently -108.33%.
Wall Street Analysts Forecast Growth
PHG has been the topic of a number of research reports. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Jefferies Financial Group upgraded shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Thursday, February 20th. Finally, BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.
View Our Latest Research Report on PHG
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- Business Services Stocks Investing
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- How to Capture the Benefits of Dividend Increases
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.